NEOGENE THERAPEUTICS
Neogene Therapeutics provides cancer patients with T cell therapies targeting mutated proteins called neo-antigens. The company is developing novel technologies to enable the engineering of ‘designer T cells’ with neo-antigen specificities that display an optimized ability to seek and destroy cancer cells. Neogene's platform allows for the isolation of neo-antigen specific TCR genes from tumor biopsies that are routinely obtained from cancer patients during treatment. The tumor-infiltrating... lymphocytes (TIL) obtained by these tumor biopsies frequently express TCRs specific for mutated proteins found in cancer cells (neo-antigens). The company’s proprietary technology uses state-of-the-art DNA sequencing, DNA synthesis and genetic screening tools to identify such neo-antigen specific T cell receptor genes within tumor biopsies with high sensitivity, specificity and at scale.
NEOGENE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2018-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.neogene.com
Total Employee:
11+
Status:
Active
Total Funding:
125 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Sitelinks Search Box
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Founder
Investors List
Pontifax
Pontifax investment in Series A - Neogene Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series A - Neogene Therapeutics
Two River
Two River investment in Series A - Neogene Therapeutics
Jeito Capital
Jeito Capital investment in Series A - Neogene Therapeutics
Vida Ventures
Vida Ventures investment in Series A - Neogene Therapeutics
TPG
TPG investment in Series A - Neogene Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Neogene Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series A - Neogene Therapeutics
Key Employee Changes
Official Site Inspections
http://www.neogene.com Semrush global rank: 4.36 M Semrush visits lastest month: 2.6 K
- Host name: 13.137.62.50.host.secureserver.net
- IP address: 50.62.137.13
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Neogene Therapeutics"
Home - Neogene Therapeutics
To find out more, read our policies below. by pioneering next-generation, neoantigen-targeting engineered T cell receptor therapies for solid cancers. ©2024 Neogene Therapeutics.See details»
AstraZeneca to acquire Neogene Therapeutics,
Nov 29, 2022 · AstraZeneca today announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, …See details»
About Us - Neogene Therapeutics
Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) …See details»
AstraZeneca to acquire Neogene Therapeutics, accelerating …
Neogene Therapeutics, Inc. is a global, clinical-stage biotechnology company focused on discovering, developing and manufacturing next-generation, transformative TCR therapies …See details»
Neogene Therapeutics - Crunchbase Company Profile …
Neogene Therapeutics provides cancer patients with T cell therapies targeting mutated proteins called neo-antigens. The company is developing novel technologies to enable the engineering of ‘designer T cells’ with neo-antigen …See details»
AstraZeneca to acquire Neogene Therapeutics, accelerating …
Nov 29, 2022 · AstraZeneca today announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, …See details»
AstraZeneca to acquire Neogene Therapeutics - FT.com
Nov 29, 2022 · AstraZeneca today announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, …See details»
AstraZeneca to acquire Neogene Therapeutics - NLS - Nordic Life …
Dec 2, 2022 · AstraZeneca has announced an agreement to acquire Neogene Therapeutics, a global clinical-stage biotechnology company focusing on the discovery, development and …See details»
AstraZeneca Acquires Neogene, Expanding in Cancer Cell Therapy
Nov 30, 2022 · AstraZeneca is acquiring Neogene Therapeutics for up to $320 million cash, bolstering its portfolio of cancer-fighting cell therapies.See details»
Neogene Picks Cell Therapy Hub Santa Monica as U.S.
On June 21, 2021, Biospacereported, Amsterdam-based Neogene Therapeutics, which launched in 2018, is setting up its U.S. headquarters in Santa Monica, California.See details»
Our Science - Neogene Therapeutics
Neogene leverages its portfolio of tumor-specific TCRs targeting hotspot mutations in KRAS and TP53, its proprietary TCR identification and selection platform and T cell engineering technologies to overcome these limitations. …See details»
Neogene Therapeutics Company Profile 2024: Valuation, Funding ...
Operator of a biotechnology company intended to develop next-generation, fully personalized engineered T-cell therapies for a broad spectrum of cancers.See details»
What is Neogene Therapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Neogene Therapeutics. Salaries, reviews, and more - all posted by employees working at Neogene Therapeutics.See details»
International Commission on Stratigraphy
Neogene Timescale. About SNS Organization. The Subcommission on Neogene Stratigraphy (SNS) is part of the International Commission on Stratigraphy (ICS) of the International Union …See details»
Neogene - Wikipedia
The Neogene (/ ˈ n iː. ə dʒ iː n / NEE-ə-jeen, [6] [7]) is a geologic period and system that spans 20.45 million years from the end of the Paleogene Period 23.03 million years ago to the …See details»
Neogene burial of organic carbon in the global ocean | Nature
Jan 4, 2023 · In this study, we establish the rate of global OC burial over the Neogene period by using measurements of total OC (TOC%) and dry bulk density (DBD), alongside well …See details»
Neogene Therapeutics Appoints Raphaël Rousseau, M.D., Ph.D., as …
Dr. Rousseau brings extensive scientific expertise and industry experience in the development of T cell therapies and will lead Neogene’s efforts to advance next-generation, fully individualized …See details»
Neogene - New World Encyclopedia
The Neogene period is a unit of the geologic time scale starting 23.03 ± 0.05 million years ago (mya). It is the second of two periods that mark our current era, the Cenozoic , beginning at …See details»
Acquisition of Neogene Therapeutics completed - AstraZeneca
Jan 16, 2023 · AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, …See details»
world’s largest worm lizard: a new giant trogonophid (Squamata ...
Nov 21, 2024 · Abstract. We here describe Terastiodontosaurus marcelosanchezi, a new amphisbaenian genus and species from the Eocene of Chambi, Tunisia.Using micro …See details»